Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Genentech Inc. (DNA)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
Cramer
Authors on DNA
Newest on DNA
The Burrill Report
(1)
Smart Profits Report
(2)
Larry Rothman
(1)
Mark Cifra
(1)
Ron Sommer
(1)
Most frequent on DNA
SA Editor Miriam Metzinger
(
57
)
Centient Biotech Investor
(
32
)
Mike Huckman
(
30
)
Market Folly
(
18
)
SA Editor Eli Hoffmann
(
17
)
Most followed on DNA
Philip Davis
(
2637
)
Don Dion
(
2261
)
Bespoke Investment Group
(
2208
)
Trader Mark
(
2080
)
SA Editor Rachael Granby
(
1319
)
Most commented on DNA
SA Editor Eli Hoffmann
(
96
)
SA Editor Rachael Granby
(
91
)
SA Editor Miriam Metzinger
(
44
)
SA Editor Joan Wickham
(
43
)
Market Folly
(
42
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Genentech Inc. (DNA)
by
latest
|
most commented
Alyeska Favors Energy Producers
Jul 8
•
Market Folly
•
DNA
,
ETR
,
HON
•
1 Comment
|
Quick Read
Comparing Medicine’s Cost and Effectiveness
Jul 1
•
Eric Savitz
•
BMY
,
AMED
,
ABT
•
6 Comments
|
Quick Read
Hedge Fund Moore Stakes Out Energy Bets
Jul 1
•
Market Folly
•
ACE
,
AMR
,
ATVI
•
1 Comment
|
Quick Read
Eminence Making a Lab Services Bet?
Jun 26
•
Market Folly
•
A
,
ABT
,
AAPL
•
1 Comment
|
Quick Read
Life Science Looks to Big Pharma for Funding as Caution Still Reigns
Jun 15
•
The Burrill Report
•
DNA
,
MRK
•
Comment!
|
Quick Read
Galleon Bets Heavily on the S&P 500
Jun 9
•
Market Folly
•
AMAG
,
AMD
,
AMAT
•
Comment!
|
Quick Read
Genentech's 'Good' Subsidy Hardly Helps Economic Development
May 31
•
Dr. Bill Conerly
•
DNA
•
1 Comment
|
Quick Read
Blue Ridge Capital: One Hedge Fund That's Done With Gold
May 27
•
Market Folly
•
AMGN
,
AEM
,
AAPL
•
8 Comments
|
Quick Read
What's John Paulson Buying Now? Hint... Think Gold
May 20
•
Market Folly
•
BCE
,
BSX
,
AU
•
12 Comments
|
Quick Read
Swine Flu: Trade Smartly, Beware the Hype
Apr 30
•
Mike Stathis
•
AMGN
,
CELG
,
BCRX
•
23 Comments
|
Quick Read
Personalized Medicine: The Next Big Thing
Apr 29
•
Andrew Mickey
•
DNA
,
LLY
,
GSK
•
5 Comments
|
Quick Read
Galleon's Q408: SPY Pays Off Alongside Reduced Equity Positions
Apr 21
•
Market Folly
•
AEO
,
ADI
,
AAPL
•
Comment!
|
Quick Read
Quantitative Price Action Screen: Features to Look For
Apr 15
•
Richard Shaw
•
BIDU
,
APC
,
AAPL
•
2 Comments
|
Quick Read
That Was Not a 2:1 Split in BBH
Apr 5
•
Ron Rowland
•
DNA
,
AMGN
,
BBH
•
14 Comments
|
Quick Read
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Apr 2
•
Mark Cifra
•
CVTX
,
ARNA
,
ACOR
•
5 Comments
|
Quick Read
FDA and Clinical Trial Updates: Weight Loss, Diabetes and More
Apr 2
•
Mike Havrilla
•
ARNA
,
ACOR
,
AZN
•
2 Comments
|
Quick Read
Genentech Seals Roche's Dominance of Oncology Market
Apr 1
•
EP Vantage
•
DNA
,
RHHBY.PK
•
Comment!
|
Quick Read
Successfully Investing in Biotech: Smaller Companies, Lots of Patience
Apr 1
•
Ron Sommer
•
DNA
,
ENDP
,
RHHBY.PK
•
Comment!
|
Quick Read
Immunogen: Moving on Up
Mar 27
•
Beta Delta
•
IMGN
,
DNA
•
Comment!
|
Quick Read
Wall Street Breakfast: Must-Know News
Mar 26
•
SA Editor Rachael Granby
•
C
,
BAC
,
DIA
•
12 Comments
|
Quick Read
Eric Mindich's Eton Park Capital Likes Gold
Mar 26
•
Market Folly
•
ALO
,
AKAM
,
ANR
•
1 Comment
|
Quick Read
Bear Market Rally Not Over Yet
Mar 22
•
Tsachy Mishal
•
ROH
,
DNA
,
DIA
•
3 Comments
|
Quick Read
Good News for Roche and Excellent News For Immunogen
Mar 20
•
Ohad Hammer
•
IMGN
,
DNA
,
RHHBY.PK
•
Comment!
|
Quick Read
Is the Winner Pfizer, Merck or Roche?
Mar 20
•
Larry Rothman
•
DNA
,
PFE
,
MRK
•
11 Comments
|
Quick Read
Moore Capital Investments: Theme Is Economic Recovery
Mar 18
•
Market Folly
•
ACE
,
AKS
,
AHBIF.PK
•
3 Comments
|
Quick Read
Tudor Investment Takes New Positions in Financials, Among Others
Mar 17
•
Market Folly
•
AEO
,
ACN
,
A
•
3 Comments
|
Quick Read
Where Might Genentech Investors Redeploy $47B?
Mar 16
•
Michael Becker
•
AMAG
,
ALXN
,
ACOR
•
2 Comments
|
Quick Read
Big Mergers Could Mean Sweet Gains for Biotech
Mar 13
•
Smart Profits Report
•
BIIB
,
AMGN
,
BBH
•
6 Comments
|
Quick Read
Profitability Propelled the Recent Rally
Mar 13
•
Chris Krasowski
•
DNA
,
C
,
BAC
•
3 Comments
|
Quick Read
Biotech Is Now the Place to Be for Big Pharma
Mar 13
•
Money Morning
•
BMY
,
CELG
,
AMLN
•
2 Comments
|
Quick Read
Thursday's Options Recap
Mar 12
•
Frederic Ruffy
•
CAL
,
AMR
,
AKS
•
1 Comment
|
Quick Read
Waxman's Bill Is Bad for Biotech
Mar 12
•
Zacks.com
•
DNA
,
AMGN
,
WYE
•
6 Comments
|
Quick Read
Roche / Genentech Is a Done Deal
Mar 12
•
Derek Lowe
•
DNA
,
RHHBY.PK
•
4 Comments
|
Quick Read
Biotech Dip: Sector Weakness, or Buying Opportunity?
Mar 12
•
Hans Wagner
•
DNA
,
AMGN
,
GENZ
•
4 Comments
|
Quick Read
Wall Street Breakfast: Must-Know News
Mar 12
•
SA Editor Rachael Granby
•
CSG
,
AMZN
,
DIA
•
12 Comments
|
Quick Read
Preview from Europe: The Horror Show's Alive and Well
Mar 12
•
The Mole
•
COST
,
BAC
,
BULIF.PK
•
13 Comments
|
Quick Read
Maverick Capital's 13F Filing for Q408
Mar 12
•
Market Folly
•
AMGN
,
AMD
,
AAPL
•
3 Comments
|
Quick Read
When Will the Genentech Roller Coaster End?
Mar 11
•
Mike Huckman
•
DNA
,
RHHBY.PK
•
2 Comments
|
Quick Read
Speculation Runs High Over New Dow Jones Candidates
Mar 10
•
Kirk Shinkle
•
AFL
,
ABT
,
AAPL
•
5 Comments
|
Quick Read
Pharma: Are Mega Mergers Good for Business?
Mar 10
•
Eben Tessari
•
DNA
,
LLY
,
MRK
•
2 Comments
|
Quick Read
Equities Shrivel as Day Wears On
Mar 10
•
Bill Cara
•
DNA
,
AMGN
,
DIA
•
Comment!
|
Quick Read
1
2
3
4
5
6
...
9
Next Page